TAS-102 is an orally administered combination of a thymidine-based nucleic acid analogue, trifluridine, and a thymidine phosphorylase inhibitor, tipiracil hydrochloride.
TrustPilot
尤素夫·A.
1 个月前
法蒂玛 A.
3天前
Ayesha M.
5天前
Anjali K.